Kinolsen Pharmaceuticals (Opc) Private Limited - Company Profile

It is a business services enterprise based in Venkatapuram Vellore, Tamil Nadu, India, established in 2017.
2017 Venkatapuram Vellore, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Kinolsen Pharmaceuticals (Opc) Private Limited

Kinolsen Pharmaceuticals (Opc) Private Limited, Engaging in other services within the business services sector, it holds CIN: U74999TN2017OPC114927. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Ramamoorthy Suresh Babu (Director). It is based at Plot No.7,S.No.165/2A, 3A Balamurugan Nagar,, Venkatapuram Vellore, Tamil Nadu, 632006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TN2017OPC114927

  • Registration Number

    114927

  • Incorporation Date

    13 February 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 13 Days
Company report

Kinolsen Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kinolsen Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kinolsen Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramamoorthy Suresh Babu Director 13 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kinolsen Pharmaceuticals (Opc).

Enhance accessibility to Kinolsen Pharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kinolsen Pharmaceuticals (Opc) revenue growth over time
Kinolsen Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kinolsen Pharmaceuticals (Opc)?

Unlock access to Kinolsen Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kinolsen Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Kinolsen Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kinolsen Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kinolsen Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kinolsen Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Director Appointment

    The activity Ramamoorthy Suresh Babu was appointed as a Director was appointed as a Director on 13 Feb 2017 & has been associated with this company since 9 years 13 days . was completed.

  • Company Incorporation

    Progress on Kinolsen Pharmaceuticals (Opc) Private Limited was registered on 13 Feb 2017 with Roc Chennai & aged 9 years 13 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kinolsen Pharmaceuticals (Opc) Private Limited?

The CIN of Kinolsen Pharmaceuticals (Opc) Private Limited is U74999TN2017OPC114927.

Where is Kinolsen Pharmaceuticals (Opc) Private Limited headquartered?

Kinolsen Pharmaceuticals (Opc) Private Limited is headquartered at Plot No.7,S.No.165/2A, 3A Balamurugan Nagar,, Venkatapuram Vellore, Tamil Nadu, 632006.

When was Kinolsen Pharmaceuticals (Opc) Private Limited incorporated?

Kinolsen Pharmaceuticals (Opc) Private Limited was incorporated on 13 February 2017.

Who are the current directors of Kinolsen Pharmaceuticals (Opc) Private Limited?

The current directors of Kinolsen Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Kinolsen Pharmaceuticals (Opc) Private Limited?

The primary industry of Kinolsen Pharmaceuticals (Opc) Private Limited is Business Services.

Is Kinolsen Pharmaceuticals (Opc) Private Limited a listed company?

Kinolsen Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Kinolsen Pharmaceuticals (Opc) Private Limited?

The authorized capital of Kinolsen Pharmaceuticals (Opc) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Kinolsen Pharmaceuticals (Opc) Private Limited?

The compliance status of Kinolsen Pharmaceuticals (Opc) Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available